Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatic Encephalopathy | 10 | 2025 | 75 | 5.420 |
Why?
|
| Liver Failure, Acute | 7 | 2025 | 89 | 3.480 |
Why?
|
| Liver | 14 | 2025 | 1748 | 2.400 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2019 | 129 | 2.110 |
Why?
|
| Cholestasis | 8 | 2021 | 154 | 1.790 |
Why?
|
| Chemical and Drug Induced Liver Injury | 3 | 2025 | 108 | 1.660 |
Why?
|
| Signal Transduction | 12 | 2024 | 4591 | 1.470 |
Why?
|
| Microglia | 3 | 2024 | 102 | 1.430 |
Why?
|
| Mice, Inbred C57BL | 15 | 2025 | 4418 | 1.390 |
Why?
|
| Thrombospondin 1 | 2 | 2020 | 24 | 1.360 |
Why?
|
| Bile Ducts | 8 | 2021 | 53 | 1.340 |
Why?
|
| Bile Acids and Salts | 3 | 2016 | 244 | 1.280 |
Why?
|
| Acetaminophen | 2 | 2020 | 92 | 1.230 |
Why?
|
| Azoxymethane | 7 | 2025 | 11 | 1.200 |
Why?
|
| Up-Regulation | 5 | 2019 | 875 | 1.060 |
Why?
|
| Disease Models, Animal | 15 | 2025 | 4405 | 0.980 |
Why?
|
| CD47 Antigen | 1 | 2024 | 8 | 0.940 |
Why?
|
| Benzamides | 3 | 2019 | 110 | 0.870 |
Why?
|
| Mice, Knockout | 7 | 2024 | 3751 | 0.800 |
Why?
|
| Glutathione | 2 | 2020 | 195 | 0.770 |
Why?
|
| Hepatocytes | 2 | 2020 | 210 | 0.730 |
Why?
|
| Galanin | 2 | 2020 | 6 | 0.720 |
Why?
|
| Cell Death | 4 | 2024 | 240 | 0.690 |
Why?
|
| Liver Cirrhosis | 6 | 2021 | 844 | 0.690 |
Why?
|
| Mice | 22 | 2025 | 17736 | 0.670 |
Why?
|
| Blood-Brain Barrier | 3 | 2015 | 143 | 0.670 |
Why?
|
| Chemokine CCL2 | 2 | 2025 | 123 | 0.670 |
Why?
|
| Animals | 32 | 2025 | 34298 | 0.670 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 2017 | 80 | 0.660 |
Why?
|
| Pyrazoles | 2 | 2019 | 306 | 0.650 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2019 | 88 | 0.620 |
Why?
|
| Pituitary-Adrenal System | 3 | 2017 | 37 | 0.620 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2017 | 64 | 0.610 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 455 | 0.610 |
Why?
|
| Hypothalamus | 3 | 2017 | 213 | 0.580 |
Why?
|
| Pineal Gland | 1 | 2017 | 19 | 0.560 |
Why?
|
| Melatonin | 1 | 2017 | 27 | 0.550 |
Why?
|
| Carcinogens | 4 | 2019 | 152 | 0.540 |
Why?
|
| Chemokine CX3CL1 | 1 | 2016 | 3 | 0.530 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 466 | 0.520 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2015 | 296 | 0.510 |
Why?
|
| Claudin-5 | 1 | 2015 | 3 | 0.490 |
Why?
|
| Inflammation | 7 | 2021 | 1444 | 0.480 |
Why?
|
| Encephalitis | 1 | 2016 | 111 | 0.480 |
Why?
|
| Capillary Permeability | 1 | 2015 | 75 | 0.470 |
Why?
|
| Central Nervous System Diseases | 1 | 2015 | 108 | 0.470 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 139 | 0.460 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 114 | 0.430 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 376 | 0.420 |
Why?
|
| Cell Proliferation | 10 | 2020 | 2371 | 0.410 |
Why?
|
| Bile Ducts, Intrahepatic | 4 | 2015 | 97 | 0.410 |
Why?
|
| Oxidative Stress | 3 | 2025 | 818 | 0.390 |
Why?
|
| Homeostasis | 1 | 2016 | 704 | 0.380 |
Why?
|
| Neurons | 2 | 2019 | 1941 | 0.380 |
Why?
|
| Phosphorylation | 4 | 2020 | 1637 | 0.370 |
Why?
|
| Nervous System Diseases | 1 | 2014 | 375 | 0.340 |
Why?
|
| Male | 22 | 2025 | 61573 | 0.310 |
Why?
|
| Morpholinos | 4 | 2017 | 10 | 0.310 |
Why?
|
| Cholangiocarcinoma | 4 | 2014 | 107 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2018 | 1242 | 0.280 |
Why?
|
| Bile Duct Neoplasms | 3 | 2014 | 109 | 0.280 |
Why?
|
| Antioxidants | 2 | 2020 | 353 | 0.270 |
Why?
|
| Ligation | 5 | 2021 | 131 | 0.270 |
Why?
|
| Rats | 7 | 2021 | 3725 | 0.270 |
Why?
|
| Apoptosis | 2 | 2025 | 1816 | 0.250 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2025 | 8 | 0.240 |
Why?
|
| Smad3 Protein | 2 | 2015 | 58 | 0.230 |
Why?
|
| Hepatic Stellate Cells | 3 | 2021 | 21 | 0.230 |
Why?
|
| Problem-Based Learning | 1 | 2024 | 72 | 0.220 |
Why?
|
| Writing | 1 | 2024 | 62 | 0.220 |
Why?
|
| Cell Line | 4 | 2017 | 2754 | 0.220 |
Why?
|
| Down-Regulation | 2 | 2016 | 690 | 0.210 |
Why?
|
| Interleukin-6 | 3 | 2018 | 420 | 0.200 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2025 | 682 | 0.190 |
Why?
|
| Receptors, Leptin | 1 | 2021 | 40 | 0.190 |
Why?
|
| Disease Progression | 2 | 2025 | 2081 | 0.180 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 2017 | 58 | 0.180 |
Why?
|
| Hyperplasia | 2 | 2021 | 200 | 0.180 |
Why?
|
| Liver Regeneration | 1 | 2020 | 36 | 0.180 |
Why?
|
| Education, Medical | 1 | 2024 | 289 | 0.180 |
Why?
|
| Receptors, Ghrelin | 1 | 2020 | 28 | 0.170 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2012 | 283 | 0.170 |
Why?
|
| Receptors, LHRH | 2 | 2017 | 12 | 0.170 |
Why?
|
| Ghrelin | 1 | 2020 | 52 | 0.170 |
Why?
|
| Receptor, Galanin, Type 1 | 1 | 2020 | 1 | 0.170 |
Why?
|
| Receptor, Galanin, Type 2 | 1 | 2020 | 2 | 0.170 |
Why?
|
| Bilirubin | 2 | 2021 | 124 | 0.170 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2020 | 114 | 0.160 |
Why?
|
| Isoquinolines | 1 | 2019 | 40 | 0.160 |
Why?
|
| Cell Line, Transformed | 1 | 2019 | 169 | 0.160 |
Why?
|
| Protective Agents | 1 | 2019 | 35 | 0.150 |
Why?
|
| Pyridostigmine Bromide | 1 | 2018 | 13 | 0.150 |
Why?
|
| Permethrin | 1 | 2018 | 7 | 0.150 |
Why?
|
| Keratin-19 | 2 | 2015 | 3 | 0.150 |
Why?
|
| Necrosis | 1 | 2019 | 209 | 0.150 |
Why?
|
| Thioacetamide | 1 | 2018 | 3 | 0.150 |
Why?
|
| Persian Gulf Syndrome | 1 | 2018 | 15 | 0.150 |
Why?
|
| DEET | 1 | 2018 | 26 | 0.150 |
Why?
|
| Phagocytosis | 1 | 2019 | 171 | 0.150 |
Why?
|
| Probiotics | 1 | 2021 | 214 | 0.150 |
Why?
|
| Brain | 3 | 2021 | 3009 | 0.140 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 495 | 0.140 |
Why?
|
| Antibodies | 1 | 2019 | 374 | 0.140 |
Why?
|
| Central Nervous System Depressants | 1 | 2017 | 21 | 0.140 |
Why?
|
| Pyrroles | 1 | 2019 | 184 | 0.140 |
Why?
|
| Pyridines | 1 | 2019 | 235 | 0.140 |
Why?
|
| Hormone Antagonists | 1 | 2017 | 60 | 0.140 |
Why?
|
| Receptors, Galanin | 1 | 2017 | 1 | 0.140 |
Why?
|
| Acute-Phase Reaction | 1 | 2017 | 12 | 0.140 |
Why?
|
| Liver Diseases | 1 | 2021 | 367 | 0.130 |
Why?
|
| Regeneration | 1 | 2019 | 211 | 0.130 |
Why?
|
| Infusions, Intraventricular | 1 | 2016 | 14 | 0.130 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 105 | 0.130 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2016 | 31 | 0.130 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2017 | 151 | 0.130 |
Why?
|
| Cholic Acid | 1 | 2015 | 18 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2015 | 408 | 0.130 |
Why?
|
| Alanine Transaminase | 1 | 2016 | 159 | 0.130 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2015 | 34 | 0.130 |
Why?
|
| Cholestyramine Resin | 1 | 2015 | 13 | 0.130 |
Why?
|
| Organic Anion Transporters, Sodium-Dependent | 1 | 2015 | 28 | 0.120 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2015 | 6 | 0.120 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2015 | 8 | 0.120 |
Why?
|
| Secretin | 1 | 2015 | 15 | 0.120 |
Why?
|
| Triterpenes | 1 | 2015 | 21 | 0.120 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2015 | 14 | 0.120 |
Why?
|
| Receptors, Gastrointestinal Hormone | 1 | 2015 | 9 | 0.120 |
Why?
|
| Nerve Growth Factor | 1 | 2015 | 21 | 0.120 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2015 | 44 | 0.120 |
Why?
|
| Receptors, Somatostatin | 1 | 2015 | 54 | 0.120 |
Why?
|
| Autocrine Communication | 1 | 2015 | 28 | 0.120 |
Why?
|
| Symporters | 1 | 2015 | 70 | 0.120 |
Why?
|
| Cytokines | 2 | 2021 | 1288 | 0.120 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 326 | 0.120 |
Why?
|
| Epithelial Cells | 2 | 2020 | 909 | 0.120 |
Why?
|
| Body Weight | 2 | 2021 | 989 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 2017 | 384 | 0.120 |
Why?
|
| Paracrine Communication | 1 | 2015 | 69 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2021 | 493 | 0.120 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2014 | 35 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 276 | 0.110 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 413 | 0.110 |
Why?
|
| Neuroglia | 1 | 2016 | 206 | 0.110 |
Why?
|
| Deoxycholic Acid | 1 | 2014 | 13 | 0.110 |
Why?
|
| Chenodeoxycholic Acid | 1 | 2014 | 13 | 0.110 |
Why?
|
| Neprilysin | 1 | 2014 | 19 | 0.110 |
Why?
|
| Autopsy | 1 | 2014 | 110 | 0.110 |
Why?
|
| Tight Junctions | 1 | 2014 | 39 | 0.110 |
Why?
|
| Substance P | 1 | 2014 | 36 | 0.110 |
Why?
|
| Flow Cytometry | 1 | 2016 | 801 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2020 | 3041 | 0.110 |
Why?
|
| Body Temperature | 1 | 2014 | 118 | 0.110 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2014 | 66 | 0.110 |
Why?
|
| Microvessels | 1 | 2014 | 57 | 0.110 |
Why?
|
| Cholesterol | 1 | 2016 | 540 | 0.110 |
Why?
|
| Stress, Psychological | 1 | 2018 | 558 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 2412 | 0.110 |
Why?
|
| Quinazolines | 1 | 2014 | 175 | 0.110 |
Why?
|
| Glycine | 1 | 2014 | 168 | 0.100 |
Why?
|
| Hedgehog Proteins | 1 | 2014 | 254 | 0.100 |
Why?
|
| Monoamine Oxidase | 1 | 2012 | 11 | 0.100 |
Why?
|
| Choledochal Cyst | 1 | 2012 | 8 | 0.100 |
Why?
|
| Sirtuin 1 | 1 | 2012 | 43 | 0.100 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2017 | 361 | 0.100 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2011 | 7 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2017 | 1033 | 0.090 |
Why?
|
| DNA | 1 | 2017 | 1616 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 587 | 0.090 |
Why?
|
| Biomarkers | 2 | 2018 | 3093 | 0.090 |
Why?
|
| Forkhead Box Protein O1 | 3 | 2020 | 89 | 0.090 |
Why?
|
| Time Factors | 3 | 2017 | 6318 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2014 | 3309 | 0.080 |
Why?
|
| Humans | 8 | 2024 | 125331 | 0.060 |
Why?
|
| Corticosterone | 2 | 2017 | 58 | 0.060 |
Why?
|
| Cyclic AMP | 2 | 2015 | 247 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2014 | 2602 | 0.060 |
Why?
|
| Biomarkers, Tumor | 1 | 2011 | 1534 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2014 | 256 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2014 | 725 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2014 | 3415 | 0.050 |
Why?
|
| Ammonium Compounds | 1 | 2021 | 1 | 0.050 |
Why?
|
| Inositol | 1 | 2021 | 13 | 0.050 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2021 | 28 | 0.040 |
Why?
|
| Transaminases | 1 | 2020 | 32 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2014 | 1001 | 0.040 |
Why?
|
| Acetyltransferases | 1 | 2020 | 89 | 0.040 |
Why?
|
| Bifidobacterium | 1 | 2021 | 62 | 0.040 |
Why?
|
| Leptin | 1 | 2021 | 213 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 2 | 2012 | 359 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2021 | 380 | 0.040 |
Why?
|
| Glutamine | 1 | 2021 | 215 | 0.040 |
Why?
|
| Immobilization | 1 | 2018 | 24 | 0.040 |
Why?
|
| Female | 4 | 2021 | 66836 | 0.040 |
Why?
|
| CD11b Antigen | 1 | 2018 | 36 | 0.040 |
Why?
|
| Metabolome | 1 | 2021 | 292 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2021 | 489 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 469 | 0.040 |
Why?
|
| Feces | 1 | 2021 | 727 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2021 | 1133 | 0.030 |
Why?
|
| Monocytes | 1 | 2018 | 345 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2017 | 314 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 1980 | 0.030 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2015 | 13 | 0.030 |
Why?
|
| Somatostatin | 1 | 2015 | 70 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2015 | 63 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2015 | 108 | 0.030 |
Why?
|
| Cell Movement | 1 | 2018 | 854 | 0.030 |
Why?
|
| Middle Aged | 1 | 2014 | 26807 | 0.030 |
Why?
|
| Zonula Occludens-2 Protein | 1 | 2014 | 7 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 461 | 0.030 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2014 | 16 | 0.030 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2014 | 4 | 0.030 |
Why?
|
| Occludin | 1 | 2014 | 18 | 0.030 |
Why?
|
| Neurokinin-1 Receptor Antagonists | 1 | 2014 | 5 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 241 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2014 | 37 | 0.030 |
Why?
|
| Aminoquinolines | 1 | 2014 | 35 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2015 | 276 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 67 | 0.030 |
Why?
|
| Permeability | 1 | 2014 | 124 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 1553 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 698 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2014 | 231 | 0.030 |
Why?
|
| Sp1 Transcription Factor | 1 | 2012 | 42 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 239 | 0.020 |
Why?
|
| 1-Naphthylisothiocyanate | 1 | 2011 | 2 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 1076 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2011 | 76 | 0.020 |
Why?
|
| Adrenalectomy | 1 | 2011 | 38 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2011 | 137 | 0.020 |
Why?
|
| Serotonin | 1 | 2012 | 217 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2011 | 312 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 914 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2011 | 217 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2014 | 377 | 0.020 |
Why?
|
| Dopamine | 1 | 2012 | 282 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2014 | 501 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1691 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 819 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 508 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 1338 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1703 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2012 | 825 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 2810 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2012 | 1051 | 0.020 |
Why?
|